BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29398096)

  • 1. Medical treatment of female overactive bladder syndrome and treatment-related effects.
    Hsiao SM; Lin HH
    J Formos Med Assoc; 2018 Oct; 117(10):871-878. PubMed ID: 29398096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for overactive bladder.
    Karmarkar R; Khullar V
    Expert Opin Emerg Drugs; 2015; 20(4):613-24. PubMed ID: 26359223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
    Ellsworth P
    Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Bywater M; Kessler TM
    Praxis (Bern 1994); 2017; 106(21):1175-1181. PubMed ID: 29041854
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding clinic options for overactive bladder.
    Bartley JM; Blum ES; Sirls LT; Peters KM
    Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence in the treatment of overactive bladder.
    Brown ET; Martin L; Dmochowski RR
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):366-72. PubMed ID: 26308197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies in the treatment of overactive bladder.
    Yeo EK; Hashim H; Abrams P
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):319-37. PubMed ID: 23885696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing overactive bladder.
    Robinson D; Cardozo L
    Climacteric; 2019 Jun; 22(3):250-256. PubMed ID: 31034265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of refractory OAB in the non-neurogenic patient.
    Wadie BS
    Curr Urol Rep; 2014 Sep; 15(9):438. PubMed ID: 25015301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of overactive bladder syndrome.
    Srikrishna S; Robinson D; Cardozo L; Vella M
    Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overactive Bladder in Frail Older Adults.
    Shaw C; Wagg A
    Drugs Aging; 2020 Aug; 37(8):559-565. PubMed ID: 32557178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
    Hsiao SM; Lin HH; Kuo HC
    PLoS One; 2016; 11(1):e0147137. PubMed ID: 26824901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overactive bladder syndrome--a public health challenge].
    Veit-Rubin N; Meyer S; Achtari C
    Rev Med Suisse; 2015 Oct; 11(492):2016-21. PubMed ID: 26672181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB).
    El-Zawahry A
    Curr Urol Rep; 2019 May; 20(6):33. PubMed ID: 31098731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard pharmacological treatment and new therapies for overactive bladder].
    Del Popolo G; Mencarini M; Li Marzi V
    Urologia; 2012; 79(1):6-13. PubMed ID: 22344568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and compliance with medication management in the treatment of overactive bladder.
    Kim TH; Lee KS
    Investig Clin Urol; 2016 Mar; 57(2):84-93. PubMed ID: 26981589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacotherapy of overactive bladder.
    Athanasopoulos A
    Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.